Frank Ruffo - Chief Financial Officer, Aclaris Therapeutics, Inc

As of June 2, 2021


Frank Ruffo Net Worth

  • Net worth is estimated to be at least $4.93M
  • Owns at least 169,872 units of Aclaris Therapeutics, Inc stock
  • Sold an estimated value of $3M in the last 6 years at Aclaris Therapeutics, Inc

Frank Ruffo Trading

  • Largest purchase of shares was 1,250 units , worth over $22.77K on May 7, 2018
  • Largest sale of shares was 87,339 units , worth over $2.31M on April 26, 2021
  • In total has made about 25 transactions over 6 years
  • Usually trades in December, with the busiest year in 2018
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Frank Ruffo Mailing Address

  • Mailing address is C/o Aclaris Therapeutics, Inc. 101 Lindenwood Drive, Suite 400 Malvern PA 19355 PA

Aclaris Therapeutics, Inc Insider Trading

  • The most recent transaction was 2,631 units sold on July 14, 2021 by David Gordon worth over $44.67K
  • In the last 6 years, insiders at Aclaris Therapeutics, Inc sold an estimated value of $87.46M and bought an estimated value of $61.5M
  • The most active traders are Kamil Alijackson, Chief Legal Officer,  Frank Ruffo, Chief Financial Officer,  and Neal Walker, President and CEO
  • Insider trading is most common in December, with the busiest year in 2018

Aclaris Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1